Nonadherence to antihypertensive drugs: A systematic review and meta-analysis

Tadesse Melaku Abegaz, Abdulla Shehab, Eyob Alemayehu Gebreyohannes, Akshaya Srikanth Bhagavathula, Asim Ahmed Elnour, Tadesse Melaku Abegaz, Abdulla Shehab, Eyob Alemayehu Gebreyohannes, Akshaya Srikanth Bhagavathula, Asim Ahmed Elnour

Abstract

Background: Hypertension drives the global burden of cardiovascular disease and its prevalence is estimated to increase by 30% by the year 2025. Nonadherence to chronic medication regimens is common; approximately 43% to 65.5% of patients who fail to adhere to prescribed regimens are hypertensive patients. Nonadherence to medications is a potential contributing factor to the occurrence of concomitant diseases.

Objective: This systematic review applied a meta-analytic procedure to investigate the medication nonadherence in adult hypertensive patients.

Methods: Original research studies, conducted on adult hypertensive patients, using the 8-item Morisky medication adherence scale (MMAS-8) to assess the medication adherence between January 2009 and March 2016 were included. Comprehensive search strategies of 3 databases and MeSH keywords were used to locate eligible literature. Study characteristics, participant demographics, and medication adherence outcomes were recorded. Effect sizes for outcomes were calculated as standardized mean differences using random-effect model to estimate overall mean effects.

Results: A total of 28 studies from 15 countries were identified, in total comprising of 13,688 hypertensive patients, were reviewed. Of 25 studies included in the meta-analysis involving 12,603 subjects, a significant number (45.2%) of the hypertensive patients and one-third (31.2%) of the hypertensive patients with comorbidities were nonadherent to medications. However, a higher proportion (83.7%) of medication nonadherence was noticed in uncontrolled blood pressure (BP) patients. Although a higher percentage (54%) of nonadherence to antihypertensive medications was noticed in females (P < 0.001), the risk of nonadherence was 1.3 times higher in males, with a relative risk of 0.883. Overall, nearly two-thirds (62.5%) of the medication nonadherence was noticed in Africans and Asians (43.5%).

Conclusion: Nonadherence to antihypertensive medications was noticed in 45% of the subjects studied and a higher proportion of uncontrolled BP (83.7%) was nonadherent to medication. Intervention models aiming to improve adherence should be emphasized.

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Nonadherence in hypertensive patients.
Figure 2
Figure 2
Nonadherence in hypertensive patients with comorbidities.
Figure 3
Figure 3
Nonadherence in uncontrolled hypertension patients.
Figure 4
Figure 4
Nonadherence in females and males.

References

    1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224–60.
    1. Burnier M. Drug adherence in hypertension. Pathophysiology and Pharmacotherapy of Cardiovascular Disease 2015;Switzerland:Springer International Publishing, 919–933.
    1. Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence for hypertension control. J Hypertens 2008;10:348–54.
    1. Svarstad BL, Chewning BA, Sleath BL, et al. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Counsel 1999;37:113–24.
    1. Kim MT, Hill MN, Bone LR, et al. Development and testing of the Hill-Bone Compliance to high blood pressure therapy scale. Progress Cardiovasc Nurs 2000;15:90–6.
    1. Culig J, Leppee M, Boskovic J, et al. Determining the difference in medication compliance between general patient population and patients receiving antihypertensive therapy: a case study. Arch Pharm Res 2011;34:1143–52.
    1. Haidich AB. Meta-analysis in medical research. Hippokratia 2010;14(suppl 1):29–37.
    1. Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344–9.
    1. Mugwano I, Kaddumukasa M, Mubenyi L, et al. Poor drug adherence and lack of awareness of hypertension among hypertensive stroke patients in Kampala, Uganda: a cross-sectional study. BMC Res Notes 2016;9:3.
    1. Sadeghi E, Behnood-Rod A, Aerab-Sheibani H, et al. Controlled blood pressure in Iranian patients: a multi-center report. Global J Health Sci 2016;8:188–95.
    1. Cummings DM, Wu J, Cene C, et al. Perceived social standing, medication nonadherence, and systolic blood pressure in the rural south. J Rural Health 2016;32:156–63.
    1. Hall E, Lee S, Clark PC, et al. Social ecology of adherence to hypertension treatment in Latino migrant and seasonal farmworkers. J Trascult Nurs 2016;27:33–41.
    1. Mohammad Y, Amal A, Sanaa A, et al. Evaluation of medication adherence in Lebanese hypertensive patients. J Epidemiol Global Health 2016;6:157–67.
    1. Yue Z, Li C, Weilin Q, et al. Application of the health belief model to improve the understanding of antihypertensive medication adherence among Chinese patients. Patient Educ Counsel 2015;98:669–73.
    1. Pandey A, Raza F, Velasco A, et al. Comparison of Morisky medication adherence scale with therapeutic drug monitoring in apparent treatment-resistant hypertension. J Am Soc Hypertens 2015;9:420–6.
    1. Akintunde AA, Akintunde TS. Antihypertensive medications adherence among Nigerian hypertensive subjects in a specialist clinic compared to a general outpatient clinic. Ann Med Health Sci Res 2015;5:173–8.
    1. Hou Y, Zhang D, Gu J, et al. The association between self-perceptions of aging and antihypertensive medication adherence in older Chinese adults. Aging Clin Exp Res 2015;28:1113–20.
    1. Saadat Z, Nikdoust F, Aerab-Sheibani H, et al. Adherence to antihypertensives in patients with comorbid conditions. Nephr Urol Mon 2015;7:e299863.
    1. Kubo MN, Kayima JK, Were AJ, et al. Factors associated with uncontrolled hypertension among renal transplant recipients attending nephrology clinics in Nairobi, Kenya. J Transplant 2015;2015:746563.
    1. Kim J, Lee W, Hong Y, et al. Psychometric properties of a short self-reported measure of medication adherence among patients with hypertension treated in a busy clinic setting in Korea. J Epidemiol 2014;24:132–40.
    1. Li WTL, Kang CD, Tsang PPM, et al. Determinants of medication adherence and blood pressure control among hypertensive patients in Hong Kong: a cross-sectional study. Int J Cardiol 2015;182:250–7.
    1. Okwuonu CG, Ojimadu NE, Okaka EI, et al. Patient-reported barriers to hypertension control in a Nigerian population. Int J Gen Med 2014;7:345–53.
    1. Fernandez-Arias M, Acuna-Villaorduna A, Miranda JJ, et al. Adherence to pharmacotherapy and medication-related beliefs in patients with hypertension in Lima, Peru. PLoS ONE 2014;9:e112875.
    1. Girma F, Emishaw S, Alemseged F, et al. Compliance with anti-hypertensive treatment and associated factors among hypertensive patients on follow-up in Jimma University specialized hospital, Jimma, south west Ethiopia: a quantitative cross-sectional study. J Hypertens 2014;3:174.
    1. Lee GKY, Wang HHX, Liu KQL, et al. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky medication adherence scale. PLoS ONE 2013;8:e62775.
    1. Cuffee YL, Hargraves JL, Briesacher BA, et al. Reported racial discrimination, trust in physicians, and medication adherence among inner-city African Americans with hypertension. Am J Public Health 2013;103:e55–62.
    1. Kretchy I, Owusu-Daaku F, Danquah S. Spiritual and religious beliefs: do they matter in the medication adherence behavior of hypertensive patients? BioPsychoSocial Med 2013;7:15.
    1. Ramli A, Ahmad NS, Paridathathu T. Medication adherence among hypertensive patients of primary health clinics in Malaysia. Patient Prefer Adherence 2012;6:613–22.
    1. Migneault JP, Dedier JJ, Wright JA, et al. A culturally adapted telecommunication system to improve physical activity, diet quality, and medication adherence among hypertensive African-Americans: a randomized controlled trial. Ann Behav Med 2012;43:62–73.
    1. Muntner P, Levitan EB, Joyce C, et al. Association between antihypertensive medication adherence and visit-to-visit variability of blood pressure. J Clin Hypertens 2013;15:112–7.
    1. Zyoud SH, Al-Jabi S, Swelleh WM, et al. Relationship of treatment satisfaction to medication adherence: findings from a cross-sectional survey among hypertensive patients in Palestine. Health Quality Life Outcome 2013;11:191.
    1. Leung LB, Busch AM, Nottage SL, et al. Approach to antihypertensive adherence: a feasibility study on the use of students health coaches for uninsured hypertensive adults. Behav Med 2012;38:19–27.
    1. Breaux-Shropshire TL, Brown KC, Pryor ER, et al. Relationship of blood pressure self-monitoring, medication adherence, self-efficacy, stage of change, and blood pressure control among municipal workers with hypertension. Workplace Health Saf 2012;60:303–11.
    1. Oliveira-Filho AD, Barreto-Filho JA, Neves SJ, et al. Association between the 8-item Morisky medication adherence scale (MMAS-8) and blood pressure control. Arq Bras Cardiol 2012;99:649–58.
    1. Holt EW, Muntner P, Joyce CJ, et al. Health-related quality of life and antihypertensive medication adherence among older adults. Age Ageing 2010;39:481–7.
    1. Berni A, Ciani E, Cecioni I, et al. Adherence to antihypertensive therapy affects ambulatory atrial stiffness index. Eur J Int Med 2011;22:93–8.
    1. Buckley L, Labonville S, Barr J. A systematic review of beliefs about hypertension and its treatment among African Americans. Curr Hypertens Rep 2016;18:52.
    1. Hyman DJ, Pavlik V. Medication adherence and resistant hypertension. J Hum Hypertens 2015;29:213–8.
    1. Waeber W, Feihi F. Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy. EuroIntervention 2013;9(suppl):R29–34.
    1. Carrea NB, Paula de Faria A, Ritter AVM, et al. A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension. J Am Soc Hypertens 2016;10:510–6.e1.
    1. Lewis LM. Factors associated with medication adherence in hypertensive blacks: a review of the literature. J Cardiovasc Nurs 2012;27:208–19.
    1. De Geest S, Ruppar T, Berben L, et al. Medication non-adherence as a critical factor in the management of presumed resistant hypertension: a narrative review. EuroIntervention 2014;9:1102–9.
    1. Pladevall M, Brotons C, Gabriel R, et al. Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study). Circulation 2010;122:1183–91.
    1. Conn VS, Enriquez M, Ruppar TM, et al. Meta-analysis of theory use in medication adherence intervention research. Am J Health Behav 2016;40:155–71.
    1. Ghembaza MA, Senoussaoui Y, Tani MK, et al. Impact of patient knowledge of hypertension complications on adherence to antihypertensive therapy. Curr Hypertens Rev 2014;10:41–8.
    1. Conn VS, Rupper TM, Chase JD, et al. Interventions to improve medication adherence in hypertensive patients: systematic review and meta-analysis. Curr Hypertens Rep 2015;17:94.
    1. Holmes HM, Luo R, Hanlon JT, et al. Ethnic disparities in adherence to antihypertensive medications of Medicare part D beneficiaries. J Am Geriatr Soc 2012;60:1298–303.
    1. Wong MC, Jiang JY, Griffiths SM. Antihypertensive drug adherence among 6408 Chinese patients on angiotensin-converting enzyme inhibitors in Hong Kong: a cohort study. J Clin Pharmacol 2010;50:598–605.
    1. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular diseases and death: a systematic review and meta-analysis. Lancet 2016;387:957–67.
    1. James P, Oparil S, Carter B, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507–20.
    1. Egan BM. Treatment resistant hypertension. Ethn Dis 2015;25:495–8.
    1. de Oliveira-Filho AD, Costa FA, Neves SJ, et al. Pseudoresistant hypertension due to poor medication adherence. Int J Cardiol 2014;172:e309–10.
    1. Holt E, Joyce C, Dornelles A, et al. Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc 2013;61:558–64.
    1. Coons SJ, Sheahan SL, Martin SS, et al. Predictors of medication noncompliance in a sample of older adults. Clin Ther 1994;16:110–7.
    1. Konin C, Adoh M, Coulibaly I, et al. Black Africans’ compliance to antihypertensive treatment. J Hypertens 2007;25:A11.
    1. Pio M, Baragou S, Afassinou Y, et al. Adherence to hypertension and its determinants in the cardiology department of the university hospital of Lome Tokoin. Pan African Med J 2012;14:48.
    1. Ikama MS, Nsitou BM, Loumouamou M, et al. Drug compliance and its factors in a group of hypertensive Congolese. Pan African Med J 2013;15:121.
    1. Ghozzi H, Kassis M, Hakim A, et al. Medication adherence of a sample of hypertensive patients in the region of Sfax (Tunisia). Ann Cardiol Angeiol 2010;59:131–7.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner